Latest Posts
-
Pharma Talks – Conversation with Frédéric Revah, CEO Genethon
13 November 2025 1. Progress of Genethon’s Gene Therapy Programs Q: How are Genethon’s programs progressing, especially in neuromuscular diseases? A: Genethon is currently advancing a robust pipeline of gene therapy programs with a strong focus on neuromuscular and metabolic disorders. One of the most significant recent achievements is the progression of the Duchenne muscular…
-
Pharma Talks – Conversation with Udo Fichtner, Graf Lambsdorff & Compagnie: Transformation requires trust – and leadership that truly understands people
28.10.2025 1. Review & Context Jens Kurth:Leadership today isn’t defined by control, but by connection. Over the past years, organizations have been forced to reinvent how they lead and collaborate. What, in your view, has changed most in leadership? Udo Fichtner:Two trends are certainly dominant. The pandemic has made remote work popular, and technology –…
-
CEO Espresso Interview: Philipp Stukenbrock
+++ Deutsche Version: siehe unten; German version below +++ Question: What makes a good negotiation? Antwort: Both partners have built a relationship of trust on equal footing and leave the negotiation with a positive feeling. The outcome works for both sides. How important is preparation for a negotiation? Very important, especially for larger projects or…